다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Journal of autoimmunity, v.85, 2017년, pp.1 - 5
Mantovani, Alberto (Humanitas Clinical and Research Center, Via Manzoni 56, 20089, Rozzano, Milan, Italy)
AI-Helper
Abstract Tumor-associated macrophages (TAM) have served as a paradigm of cancer-related inflammation. Moreover, investigations on TAM have led to the dissection of macrophage plasticity and polarization and to the discovery and analysis of molecular pathways of innate immunity, in particular cytoki...
Mantovani 2016 Non avere paura di sognare. Decalogo per aspiranti scienziati
Nature Evans 236 168 1972 10.1038/236168a0 Mechanism of immunologically specific killing of tumour cells by macrophages
J. Exp. Med. Stein 176 287 1992 10.1084/jem.176.1.287 Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation
Nat. Immunol. Biswas 11 889 2010 10.1038/ni.1937 Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Cell metab. Biswas 15 432 2012 10.1016/j.cmet.2011.11.013 Orchestration of metabolism by macrophages
J. Clin. Investig. Sica 122 787 2012 10.1172/JCI59643 Macrophage plasticity and polarization: in vivo veritas
Trends Immunol. Mantovani 23 549 2002 10.1016/S1471-4906(02)02302-5 Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes
Trends Immunol. Mantovani 25 677 2004 10.1016/j.it.2004.09.015 The chemokine system in diverse forms of macrophage activation and polarization
J. Immunol. Martinez 177 7303 2006 10.4049/jimmunol.177.10.7303 Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression
Blood Pello 119 411 2012 10.1182/blood-2011-02-339911 Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology
Nat. Rev. Immunol. Monticelli 17 10 595 2017 10.1038/nri.2017.51 Transcriptional determination and functional specificity of myeloid cells: making sense of diversity
J. Pathol. Mantovani 229 176 2013 10.1002/path.4133 Macrophage plasticity and polarization in tissue repair and remodelling
Nat. Rev. Clin. Oncol. Mantovani 14 399 2017 10.1038/nrclinonc.2016.217 Tumour-associated macrophages as treatment targets in oncology
Cancer Res. Mantovani 37 815 1977 In vitro and in vivo cytotoxicity of Adriamycin and Daunomicyn for murine macrophages
J. Natl. Cancer Inst. Mantovani 63 61 1979 Role of host defense merchanisms in the antitumor activity of adriamycin and daunomycin in mice
Annu. Rev. Immunol. Kroemer 31 51 2013 10.1146/annurev-immunol-032712-100008 Immunogenic cell death in cancer therapy
Int. J. cancer J. Int. du cancer Mantovani 22 741 1978 10.1002/ijc.2910220617 Effects on in vitro tumor growth of murine macrophages isolated from sarcoma lines differing in immunogenicity and metastasizing capacity
Immunol. today Mantovani 13 265 1992 10.1016/0167-5699(92)90008-U The origin and function of tumor-associated macrophages
Lancet Balkwill 357 539 2001 10.1016/S0140-6736(00)04046-0 Inflammation and cancer: back to Virchow?
Nature Mantovani 454 436 2008 10.1038/nature07205 Cancer-related inflammation
Science Schreiber 331 1565 2011 10.1126/science.1203486 Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion
Cell Hanahan 100 57 2000 10.1016/S0092-8674(00)81683-9 The hallmarks of cancer
Lancet Mantovani 371 771 2008 10.1016/S0140-6736(08)60241-X Tumour immunity: effector response to tumour and role of the microenvironment
Cell Hanahan 144 646 2011 10.1016/j.cell.2011.02.013 Hallmarks of cancer: the next generation
Cancer Cell Germano 23 249 2013 10.1016/j.ccr.2013.01.008 Role of macrophage targeting in the anti-tumor activity of Trabectedin
Immunity Murray 41 14 2014 10.1016/j.immuni.2014.06.008 Macrophage activation and polarization: nomenclature and experimental guidelines
J. Immunol. Mills 164 6166 2000 10.4049/jimmunol.164.12.6166 M-1/M-2 macrophages and the Th1/Th2 paradigm
Nat. Rev. Immunol. Mosser 8 958 2008 10.1038/nri2448 Exploring the full spectrum of macrophage activation
Nat. Immunol. Mantovani 17 215 2016 10.1038/ni.3354 Reflections on immunological nomenclature: in praise of imperfection
Nat. Rev. Rheumatol. Udalova 12 472 2016 10.1038/nrrheum.2016.91 Macrophage heterogeneity in the context of rheumatoid arthritis
Nat. Immunol. Netea 18 826 2017 10.1038/ni.3790 A guiding map for inflammation
J. Autoimmun. Isailovic 60 1 2015 10.1016/j.jaut.2015.04.006 Interleukin-17 and innate immunity in infections and chronic inflammation
J. Exp. Med. Colotta 165 1224 1987 10.1084/jem.165.4.1224 Expression of c-fos protooncogene in normal human peripheral blood granulocytes
Blood Colotta 80 2012 1992 10.1182/blood.V80.8.2012.2012 Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products
Nat. Rev. Immunol. Mantovani 11 519 2011 10.1038/nri3024 Neutrophils in the activation and regulation of innate and adaptive immunity
Nat. Rev. Immunol. Nathan 6 173 2006 10.1038/nri1785 Neutrophils and immunity: challenges and opportunities
Carcinogenesis Fridlender 33 949 2012 10.1093/carcin/bgs123 Tumor-associated neutrophils: friend or foe?
Biol. Blood marrow Transplant. J. Am. Soc. Blood Marrow Transplant. Dinarello 15 134 2009 10.1016/j.bbmt.2008.11.006 Inflammation in human disease: anticytokine therapy
Nat. Rev. Drug Discov. Dinarello 11 633 2012 10.1038/nrd3800 Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
Immunity Garlanda 39 1003 2013 10.1016/j.immuni.2013.11.010 The interleukin-1 family: back to the future
Blood Dejana 69 695 1987 10.1182/blood.V69.2.695.695 Modulation of endothelial cell functions by different molecular species of interleukin 1
Science Rossi 229 174 1985 10.1126/science.2409598 Prostacyclin synthesis induced in vascular cells by interleukin-1
Blood Dejana 64 1280 1984 10.1182/blood.V64.6.1280.1280 Stimulation of prostacyclin synthesis in vascular cells by mononuclear cell products
J. Exp. Med. Bevilacqua 160 618 1984 10.1084/jem.160.2.618 Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells
FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. Mantovani 6 2591 1992 Cytokine regulation of endothelial cell function
Blood Sironi 84 1913 1994 10.1182/blood.V84.6.1913.1913 Regulation of endothelial and mesothelial cell function by interleukin-13: selective induction of vascular cell adhesion molecule-1 and amplification of interleukin-6 production
Science Colotta 261 472 1993 10.1126/science.8332913 Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4
J. Exp. Med. Muzio 182 623 1995 10.1084/jem.182.2.623 Cloning and characterization of a new isoform of the interleukin 1 receptor antagonist
J. Exp. Med. Muzio 187 2097 1998 10.1084/jem.187.12.2097 The human toll signaling pathway: divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6)
Pharmacol. Rev. Bachelerie 66 1 2014 10.1124/pr.113.007724 International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors
J. Immunol. Fra 170 2279 2003 10.4049/jimmunol.170.5.2279 Cutting edge: scavenging of inflammatory CC chemokines by the promiscuous putatively silent chemokine receptor D6
Nat. Rev. Immunol. Mantovani 6 907 2006 10.1038/nri1964 Tuning inflammation and immunity by chemokine sequestration: decoys and more
Nat. Rev. Immunol. Nibbs 13 815 2013 10.1038/nri3544 Immune regulation by atypical chemokine receptors
Eur. cytokine Netw. Polentarutti 14 211 2003 Unique pattern of expression and inhibition of IL-1 signaling by the IL-1 receptor family member TIR8/SIGIRR
Proc. Natl. Acad. Sci. U. S. A. Garlanda 101 3522 2004 10.1073/pnas.0308680101 Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family
Cytokine Thomassen 11 389 1999 10.1006/cyto.1998.0452 Identification and characterization of SIGIRR, a molecule representing a novel subtype of the IL-1R superfamily
Nat. Immunol. Wald 4 920 2003 10.1038/ni968 SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling
Nat. Immunol. Nold-Petry 16 354 2015 10.1038/ni.3103 IL-37 requires the receptors IL-18Ralpha and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction
Front. Immunol. Molgora 7 149 2016 10.3389/fimmu.2016.00149 Regulatory role of IL-1R8 in immunity and disease
Nature Molgora 2017 10.1038/nature24293 IL-1R8 is a checkpoint in NK cells regulating anti-tumor and anti-viral activity
Science Bottazzi 220 210 1983 10.1126/science.6828888 Regulation of the macrophage content of neoplasms by chemoattractants
Proc. Natl. Acad. Sci. U. S. A. Rollins 85 3738 1988 10.1073/pnas.85.11.3738 Cloning and expression of JE, a gene inducible by platelet-derived growth factor and whose product has cytokine-like properties
J. Immunol. Sozzani 161 1083 1998 10.4049/jimmunol.161.3.1083 Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties
J. Exp. Med. Godiska 185 1595 1997 10.1084/jem.185.9.1595 Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells
J. Exp. Med. Bonecchi 187 129 1998 10.1084/jem.187.1.129 Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s
Cell Bonavita 160 700 2015 10.1016/j.cell.2015.01.004 PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer
Cancer Immunol. Res. Savino 2 679 2014 10.1158/2326-6066.CIR-13-0202 ERK-dependent downregulation of the atypical chemokine receptor D6 drives tumor aggressiveness in Kaposi sarcoma
J. Immunol. Solinas 185 642 2010 10.4049/jimmunol.1000413 Tumor-conditioned macrophages secrete migration-stimulating factor: a new marker for M2-polarization, influencing tumor cell motility
Annu. Rev. Immunol. Bottazzi 28 157 2010 10.1146/annurev-immunol-030409-101305 An integrated view of humoral innate immunity: pentraxins as a paradigm
Annu. Rev. Immunol. Garlanda 23 337 2005 10.1146/annurev.immunol.23.021704.115756 Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility
Nat. Immunol. Ricklin 11 785 2010 10.1038/ni.1923 Complement: a key system for immune surveillance and homeostasis
FEBS Lett. Meri 590 2418 2016 10.1002/1873-3468.12284 Self-nonself discrimination by the complement system
J. Biol. Chem. Breviario 267 22190 1992 10.1016/S0021-9258(18)41653-5 Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component
Nature Garlanda 420 182 2002 10.1038/nature01195 Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response
Physiol. Rev. Garlanda 2017 PTX3, a key component of humoral innate immunity at the interface between defense and tissue remodeling
N. Engl. J. Med. Cunha 370 421 2014 10.1056/NEJMoa1211161 Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation
Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. Wojtowicz 61 619 2015 10.1093/cid/civ386 PTX3 polymorphisms and invasive mold infections after solid organ transplant
Blood Fisher 129 2693 2017 10.1182/blood-2016-10-743294 Validation of single nucleotide polymorphisms in invasive aspergillosis following hematopoietic cell transplantation
Immunol. Rev. Erreni 280 112 2017 10.1111/imr.12570 The long pentraxin PTX3: a prototypical sensor of tissue injury and a regulator of homeostasis
Science Sharma 348 56 2015 10.1126/science.aaa8172 The future of immune checkpoint therapy
Semin. Immunol. Perretti 27 145 2015 10.1016/j.smim.2015.06.001 The resolution of inflammation: new mechanisms in patho-physiology open opportunities for pharmacology
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
저자가 공개 리포지터리에 출판본, post-print, 또는 pre-print를 셀프 아카이빙 하여 자유로운 이용이 가능한 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.